Skip to content

Tri-Con 2018: Leveraging the Cloud to Power Multi-Omics Research

The Molecular Medicine Tri-Conference kicks off next week in downtown San Francisco. Bringing together over 3,700 attendees, Tri-Con is one of the world’s leading international events in the field of drug discovery, development, and diagnostics. The program is fully-loaded with presentations highlighting advancements in cancer research, big data, molecular diagnostics, precision medicine, rare disease, human microbiome, and more.

Please join us for our presentations during the Converged IT & The Cloud program and the Microbiome-Based Precision Medicine Symposium. Can’t make it to our talks? Email us to schedule a meeting with a member of our team.

Title: The Infrastructure Requirements for Geno-Pheno Analysis on a Massive Scale
Speaker: Omar Serang, Chief Cloud Officer, DNAnexus
Talk Details: Monday, February 12th at 3:55pm – Moscone South Convention Center
Program: Converged IT & The Cloud


Learn how Biopharmas are delivering on the promise of precision medicine by leveraging genomics in R&D. A comprehensive security and privacy framework is required to provide auditability, data immutability and versioning to reproduce research. Learn about the necessary infrastructure to scale geno-pheno analysis, while maintaining stringent security and compliance controls.


Title: Mosaic, a Cloud-Based Community Platform for the Acceleration of Translational Microbiome Science
Speaker: Michalis Hadjithomas, Microbiome Lead, DNAnexus
Talk Details: Thursday, February 15th at 12:15pm, Hilton San Francisco – Union Square
Program: Microbiome-Based Precision Medicine Symposium


Mosaic provides a collaborative space where researchers can implement and compare microbiome methods through community challenges. The “Strains” series of challenges encourages the improvement of strain-level performance of bioinformatic tools. “Standards” addresses experimental and computational sources of variability in metagenomic analyses to promote accurate and reproducible NGS-based microbiome profiling. Learn more and get started at


About DNAnexus

DNAnexus the leader in biomedical informatics and data management, has created the global network for genomics and other biomedical data, operating in 33 countries including North America, Europe, China, Australia, South America, and Africa. The secure, scalable, and collaborative DNAnexus Platform helps thousands of researchers across a spectrum of industries — biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia — accelerate their genomics programs.

The DNAnexus team is made up of experts in computational biology and cloud computing who work with organizations to tackle some of the most exciting opportunities in human health, making it easier—and in many cases feasible—to work with genomic data. With DNAnexus, organizations can stay a step ahead in leveraging genomics to achieve their goals. The future of human health is in genomics. DNAnexus brings it all together.